Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities

View Activity

FACULTY

Dawn Buse, PhD
Clinical Professor, Department of Neurology
Albert Einstein College of Medicine of Yeshiva University
Assistant Professor, Clinical Health Psychology Doctoral Program
Ferkauf Graduate School of Psychology of Yeshiva University
Board Member at Large, American Headache Society

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California
Los Angeles, CA
President-Elect, American Headache Society

PROGRAM OVERVIEW

This case-based enduring activity will cover the treatment and management of patients with headache disorders, including migraine and cluster headache.

TARGET AUDIENCE

This activity is intended for primary care providers, including family practice physicians, physician assistants, and nurse practitioners who are involved in the care of patients with headache disorders, including migraine and cluster headache.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Implement best practices for the timely and accurate diagnosis of primary headache disorders in primary care settings and for referral to specialists when necessary
  • Identify the mechanisms of action and clinical profiles of new and emerging therapeutic options for the acute and preventative treatment of patients with primary headache disorders
  • Design individualized evidence-based treatment plans for patients with primary headache disorders, with focus on cluster headache, in the primary care setting
  • Utilize patient-specific factors to select therapies for patients with primary headache disorders, including quality-of-life assessment and goal setting
  • Implement strategies to effectively communicate with patients and educate them in order to establish treatment plans and encourage adherence

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this web-based activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with headache disorders, including migraine and cluster headache. CNE Credit: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

AMERICAN ASSOCIATION OF FAMILY PHYSICIANS

This activity, Diagnosing and Managing Primary Headache Disorders in the Primary Care Setting: Challenges and Opportunities from 06/29/2020–10/31/2020, has been reviewed and is acceptable for up to 1.00 elective credit by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMERICAN ASSOCIATION OF PHYSICIAN ASSISTANTS

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid from 6/29/2020 to 10/31/2021. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-200671

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

FACULTY
Dawn Buse, PhD has received consulting fees from Amgen, Allergan, Biohaven, Dr. Reddy’s, Lilly, and Teva and research grant support from Amgen, Allergan, Dr. Reddy’s, and Lilly.

Andrew Charles, MD receives consulting fees from Alder, Amgen, Biohaven, Eli Lilly, and eNeura. He has conducted research for Takeda Pharmaceuticals.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Ashley Whitehurst, Program Manager of Med Learning Group, has nothing to disclose.
Chris Drury, Medical Director of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator of Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making ability before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: July 2, 2020

EXPIRATION DATE: July 2, 2021

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at info@medlearninggroup.com

View Activity

Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.